abstract |
The invention relates to compounds of formula I or pharmaceutically acceptable salts or solvates thereof: n n n n n n n n n n where Ar 1 , A, B, R 1 , m and n are as defined in the description. The invention also includes pharmaceutical compositions and uses of, and processes of making the compounds, as well as methods of medical treatment of mGluR 5 mediated disorders. |